Reporte zur Charge 5NT4N

Symptomtext

another vaccine diluent was used to reconstitute Shingrix and administered it to a patient; This non-serious case was reported by a physician via call center representative and described the occurrence of wrong solution used in drug reconstitution in a 60-year-old male patient who received Herpes zoster (Shingrix) (batch number 5NT4N) for prophylaxis. On 07-JUN-2023, the patient received the 2nd dose of Shingrix. On 07-JUN-2023, an unknown time after receiving Shingrix, the patient experienced wrong solution used in drug reconstitution (Verbatim: another vaccine diluent was used to reconstitute Shingrix and administered it to a patient). The outcome of the wrong solution used in drug reconstitution was unknown. Additional Information: GSK receipt date: 13-JUN-2022 The physician reported that another vaccine diluent was used to reconstitute Shingrix and administered it to a patient. The vaccine administration facility was the same as primary reporter. No expiration date reported. The health care professional (HCP) reported a diluent for MMR vaccine was the one used, no further details reported. The reporter consented to follow up. The patient received diluent of MMR to reconstitute Shingrix vaccine, which led to wrong solution used in drug reconstitution.